Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
NasdaqCM - Nasdaq Real Time Price USD

Sunshine Biopharma, Inc. (SBFMW)

Compare
0.2800
+0.0784
+(38.89%)
At close: April 2 at 4:00:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
32,959.4920
24,092.7870
4,345.6030
228.4260
71.4100
Cost of Revenue
22,814.7010
15,753.6160
2,649.0280
117.8300
25.8470
Gross Profit
10,144.7910
8,339.1710
1,696.5750
110.5960
45.5630
Operating Expense
15,106.4110
13,124.4700
10,370.6060
2,550.7300
622.4370
Operating Income
-4,961.6200
-4,785.2990
-8,674.0310
-2,440.1340
-576.8740
Net Non Operating Interest Income Expense
553.9560
674.6660
479.2380
-328.8180
-168.1050
Other Income Expense
295.8820
-0.2450
-18,316.3430
-9,667.4950
-2,039.1120
Pretax Income
-4,111.7820
-4,110.8780
-26,511.1360
-12,436.4470
-2,784.0910
Tax Provision
114.1460
395.1660
233.3040
--
--
Net Income Common Stockholders
-4,225.9280
-4,506.0440
-26,744.4400
-12,436.4470
-2,784.0910
Diluted NI Available to Com Stockholders
-4,225.9280
-4,506.0440
-26,744.4400
-12,436.4470
-2,784.0910
Total Operating Income as Reported
-4,961.6200
-4,785.2990
-27,000.7500
-2,440.1340
-576.8740
Total Expenses
37,921.1120
28,878.0860
13,019.6340
2,668.5600
648.2840
Net Income from Continuing & Discontinued Operation
-4,225.9280
-4,506.0440
-26,744.4400
-12,436.4470
-2,784.0910
Normalized Income
-4,477.4277
-4,505.8970
-13,228.8105
-2,768.9520
-741.9790
Interest Income
584.3110
811.9740
518.6500
--
--
Interest Expense
30.3550
137.3080
39.4120
328.8180
168.1050
Net Interest Income
553.9560
674.6660
479.2380
-328.8180
-168.1050
EBIT
-4,081.4270
-3,973.5700
-26,471.7240
-12,107.6290
-2,615.9860
EBITDA
-3,880.9460
-3,824.4230
-26,446.5610
-12,094.8880
-2,601.9200
Reconciled Cost of Revenue
22,814.6850
15,753.6160
2,649.0280
117.8300
25.8470
Reconciled Depreciation
200.4810
149.1470
25.1630
12.7410
14.0660
Net Income from Continuing Operation Net Minority Interest
-4,225.9280
-4,506.0440
-26,744.4400
-12,436.4470
-2,784.0910
Total Unusual Items Excluding Goodwill
295.8820
-0.2450
-18,316.3430
-9,667.4950
-2,042.1120
Total Unusual Items
295.8820
-0.2450
-18,316.3430
-9,667.4950
-2,042.1120
Normalized EBITDA
-4,176.8280
-3,824.1780
-8,130.2180
-2,427.3930
-559.8080
Tax Rate for Calcs
0.0002
0.0004
0.0003
--
--
Tax Effect of Unusual Items
44.3823
-0.0980
-4,800.7135
--
--
-

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

CATV Opus Holdings, Inc.
0.0003
0.00%
 
NEUN Neurogenesis, Inc.
0.0001
0.00%
 
QMDT Quick-Med Technologies, Inc.
0.0001
0.00%
 
GSAC GelStat Corp.
0.0003
0.00%
 
SHPH Shuttle Pharmaceuticals Holdings, Inc.
0.4190
+0.82%
 
3KF.F Auxly Cannabis Group Inc.
0.0414
-4.61%
 
ACUC.ST AcuCort AB
0.7540
+1.07%
 
SFWJ Software Effective Solutions Corp.
0.0060
+9.09%
 
000538.SZ Yunnan Baiyao Group Co.,Ltd
56.96
+0.26%
 
TMSH TransGlobal Assets Inc.
0.0002
-33.33%